SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 16, 2026

TOI

Oncology Institute, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $203K total
Actionable Insight • Neutral

The insider cluster is too small to drive a trading decision. Monitor for any follow-on insider buying from C-suite or larger 10% owner purchases. The recent refinancing is the more significant catalyst; watch for Q3 earnings to assess covenant feasibility under the new OrbiMed loan.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
TOI ▼ -5.23% at T+5d
NEUTRAL call -5.23% · α vs SPY -4.55% · entry $5.35 → $5.07
Next anchor: T+20d due 3mo ago
Entry = T+0 close
Jul 16, 2026
via day close
T+1d
+2.80%
call +2.80% · α +2.97%
$5.50
settled 3mo ago
T+5d
-5.23%
call -5.23% · α -4.55%
$5.07
settled 3mo ago
T+20d
Pending
due 3mo ago
T+60d
Pending
due 18d ago

Price Chart

Loading chart...

Executive Summary

A small insider cluster at Oncology Institute (TOI) shows a 10% owner buying $88K in shares while the CMO sold $116K after exercising derivatives. The total $203K in trades represents just 0.036% of TOI's $566M market cap, making the activity trivial and likely routine. The cluster follows a major refinancing 8-K (July 7) that eliminated convertible debt overhang, but the insider moves do not provide a material signal.

Key Financial Metrics

Direction
mixed
Total Value
$203.0K
Insiders
2

Key Facts

  • CMO Podnos Yale sold $116K in open-market sales after exercising derivatives at low strike prices (routine liquidity event).
  • 10% owner Chernett Jorey bought $88K worth of shares on July 10, a modest positive signal.
  • Total cluster value of $203K is only 0.036% of TOI's $566M market cap, well below the 0.1% materiality threshold.
  • Cluster occurred 9 days after TOI's $75M OrbiMed term loan refinancing (8-K filed July 7), which removed near-term convertible debt overhang.

Financial Impact

Trivial — $203K in insider trades vs. $566M market cap (0.036%). No material financial impact.

Risk Factors

  • The CMO's sale, while routine, could signal lack of conviction if followed by additional C-suite sales.
  • The $700M minimum net revenue covenant on the OrbiMed loan starting Q4 2027 creates long-term performance pressure.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Offices & Clinics of Doctors of Medicine
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TOI-1784250065127
11 reports for TOI
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for TOI — sortable, filterable
TypeNow
Aug 3, 2026
12w ago
8-K
NEUTRAL ★ 2/10
$5.13awaiting T+20——
Jul 22, 2026
13w ago
Insider Buy
NEUTRAL ★ 2/10
$5.29awaiting T+20——
Jul 22, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$5.29awaiting T+20——
Jul 16, 2026
14w ago
Insider Cluster
NEUTRAL ★ 3/10
$5.35awaiting T+20——
Jul 13, 2026
15w ago
Insider Buy
NEUTRAL ★ 3/10
$6.25awaiting T+20——
Jul 7, 2026
15w ago
8-K
BULLISH ★ 7/10
$5.65 $5.13▼ −9.20%▼ −12.48%—
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$5.13 $5.85▲ +14.04%▲ +12.14%—
Jun 9, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$4.68 $5.85▲ +25.00%▲ +21.38%—
Apr 27, 2026
26w ago
Press Release
NEUTRAL ★ 1/10
$3.33 $4.59▲ +37.84%▲ +32.88%—
Apr 9, 2026
28w ago
Insider Cluster
MIXED ★ 5/10
$3.11 $3.80▲ +22.19%▲ +14.62%—
Showing 10 of 11

US Market Status

Market Open — Closes in 1h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 16, 2026